Editor’s Note: This is the first of a multi-part series of Q&As featuring Clinical Ink executives. Given the company’s unprecedented growth over the past few years, as well as the tremendous growth opportunities ahead, we’re giving Clinical Ink clients and our team another way to get to know some of our newest executive members. Sign up for email announcements to get notified of upcoming “meet and greets!”

As pioneers in eSource, a technology that enables electronic data capture at its inception, we’re constantly looking for ways to streamline clinical trials and minimize the time it takes to launch them. By using our Lunexis™ eSource Ecosystem, our customers shave months off their timelines due to the near-elimination of source data verification (SDV) and the ability to access and analyze data in real time.